查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929753

中國中藥檢測服務市場：按服務類型、技術、樣品類型、經營模式、檢測速度、應用和最終用戶分類，全球預測，2026-2032年

Chinese Herbal Medicine Testing Services Market by Service Type, Technology, Sample Type, Business Model, Testing Speed, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，中國草藥檢測服務市場規模將達到 13.3 億美元，到 2026 年將成長至 14.3 億美元，到 2032 年將達到 22.8 億美元，複合年成長率為 7.98%。

主要市場統計數據
基準年 2025 13.3億美元
預計年份：2026年 14.3億美元
預測年份：2032年 22.8億美元
複合年成長率 (%) 7.98%

草藥檢測服務融合了傳統知識體系和尖端分析科學，需要在文化真實性和嚴格的現代品管之間取得平衡。該行業的發展動力源於對安全性檢驗、功效評估和循證檢驗的需求，以支持國內消費和國際貿易。如今，實驗室和檢測服務供應商的營運環境日益複雜，受到不斷演變的監管標準、先進的分析技術和不斷變化的供應鏈動態的影響。因此，製造商、監管機構、研究機構和合約檢測實驗室等各方相關人員都必須應對與污染、摻假、真偽和批間差異相關的多方面風險。

在此背景下，檢測服務發揮多項關鍵作用：為品質管理計畫提供分析基礎，支援安全評估，並產生監管申報和出口合規所需的資料。傳統上，檢測模式主要集中在針對特定化學物質的分析和重金屬篩檢。然而，消費者對可追溯性和成分檢驗日益成長的需求，正推動調查方法的擴展，使其涵蓋分子鑑定和全面分析。這為專業檢測實驗室創造了機遇，使其能夠提供差異化服務，將多平台分析、綜合數據解讀和諮詢支援相結合，幫助製造商證明其產品的完整性。

隨著產業的成熟，科學研究實驗室、監管機構和供應鏈相關人員之間的合作將變得日益重要。檢測方法的統一性以及方法論和檢測極限的透明揭露對於建立從業者和消費者之間的信任至關重要。下文將探討此變革性轉變、關稅的影響、市場區隔主導的策略意義、區域差異、公司層面的趨勢，並為產業領導者提供因應此快速變化環境的實用建議。

多平台分析技術的進步和不斷變化的監管要求正在從根本上改變檢測策略和供應商關係。

植物藥的檢測格局正經歷一系列變革性的轉變，這些轉變超越了漸進式的改變，徹底改變了品質、安全性和真實性的檢驗。分子生物學的進步，特別是基於DNA的檢測技術的廣泛應用，使得在形態學或化學標記不足以識別的複雜基質中，也能可靠地進行物種鑑定和摻假檢測。結合改進的層析法分離技術和更高的質譜靈敏度，實驗室現在可以建立更詳細的化學指紋圖譜，從而揭示加工過程中的變化和細微的摻假標記。

分析關稅和貿易壁壘的變化如何推動供應鏈重組，並增加對穩健的檢驗和合規性測試的需求

近期影響進出口的新貿易措施進一步增加了檢測合規工作的複雜性，尤其是在關稅與供應鏈風險管理交織的領域。針對植物原料和成品草藥的關稅可能會促使採購模式發生變化、供應來源多元化以及關鍵成分的地理分佈轉移。這些變化可能會改變檢測申報的特徵，並隨著新的、檢驗的供應商進入市場，增加對真偽檢驗和污染物篩檢的需求。

策略性細分分析揭示了服務類型、平台技術、終端用戶需求和樣本類別如何決定實驗室能力和商業性定位。

研究結果凸顯了檢測服務機構需要根據不同相關人員，這些需求包括服務類型、技術、最終用戶、應用、樣品類型、經營模式以及檢測速度要求。就服務類型而言，化學、DNA、重金屬、微生物和農藥殘留檢測服務提供者不僅需要提供準確的分析結果，還需要提供將結果與安全性和有效性評估聯繫起來的背景解讀。服務提供者將在技術方面日益凸顯差異化優勢。層析法（包括氣相層析法和液相層析法）仍然是化學分析的基礎，而質譜法（包括GC-MS和LC-MS）則提供了微量檢測和非標靶篩檢所需的靈敏度和特異性。聚合酵素鏈鎖反應）方法（從定量PCR到數位PCR）在物種鑑定和定量方面的重要性日益凸顯，而光譜技術（例如紅外線和紫外-可見光光譜）則可作為正交分析的補充，用於快速篩檢和材料表徵。

區域趨勢和監管預期正在影響全球市場檢測需求、實驗室投資和跨境貿易準備。

區域趨勢對檢測需求、監管預期和實驗室基礎設施有顯著影響，導致美洲、歐洲、中東和非洲以及亞太地區的營運重點各不相同。在美洲，消費者對產品品質的期望以及監管審查共同塑造了市場需求，要求製造商和出口商進行全面的污染物篩檢並保持透明的文件記錄。該地區的實驗室通常專注於認證、方法檢驗和快速報告，以支援大批量生產週期和跨境貿易。

實驗室和服務供應商如何透過整合能力、諮詢服務和策略夥伴關係關係來脫穎而出並贏得長期客戶關係

實驗室服務業的企業級發展趨勢以能力、認證和服務模式的策略差異化為特徵。領先的實驗室正在投資於整合工作流程，將層析法和質譜平台與分子工具和微生物技術相結合，以提供全面、多方面的終點報告。這種技術廣度，加上強大的品管系統和外部認證，為重視監管合法性和供應鏈透明度的客戶群創造了競爭優勢。

實驗室領導者可採取實際行動，推動檢驗方法，拓展諮詢服務，並加強穩健的品質保證資料和地理策略。

產業領導者若想鞏固市場地位，應採取一系列切實可行、影響深遠的舉措，使檢查室能力與商業和監管重點保持一致。首先，應優先投資於方法驗證和跨平台協調，以確保多參數報告的科學性和法律效力。建立標準化的工作流程和透明的文件記錄將減少審核阻力，增強客戶信心，尤其對出口商和受監管的製造商更是如此。

本文將介紹我們的多源資訊來源研究途徑，該方法結合了技術審查、法規分析和專家諮詢，以確保研究結果具有實用性和科學性。

本分析的研究途徑結合了對科學文獻、監管指南和實驗室最佳實踐的多方面審查，並輔以訪談和專家諮詢，以確保其相關性和準確性。關鍵輸入包括方法檢驗標準、監管備案文件、分析技術的同行評審研究，以及來自生產和檢測實驗室的品管和合規專家的營運觀點。此外，還對包括層析法、質譜、聚合酵素鏈鎖反應和光譜在內的平台功能進行了技術評估，以評估每項技術如何幫助真偽確認、功效評估、污染物檢測和常規品管。

對決定檢查室競爭力和品質保證結果的綜合技術、監管和供應鏈趨勢進行最終評估

總之，在技術創新、不斷變化的監管要求和貿易趨勢的驅動下，支持植物療法的檢測服務生態系統正經歷著一場意義深遠的變革。投資於整合多平台能力、嚴格的方法檢驗和透明的報告機制的實驗室，將更有能力滿足製造商、監管機構和消費者的複雜需求。同時，供應鏈的波動性和貿易措施凸顯了以韌性為導向的策略的重要性，包括供應商合格、採購多元化以及支持跨境合規的文件記錄規範。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 中國中藥檢測服務市場（依服務類型分類）

  • 化學測試
  • DNA檢測
  • 重金屬檢測
  • 微生物檢測
  • 農藥殘留檢測

9. 中國中藥檢測服務市場（依技術分類）

  • 層析法
    • 氣相層析法
    • 液相層析法
  • 質譜分析
    • GC-MS
    • LC-MS
  • 聚合酵素鏈鎖反應
    • 數位PCR
    • 定量PCR
  • 光譜學
    • 紅外線光譜
    • UV-Vis

第10章：中國中藥檢測服務市場（依樣本類型分類）

  • 營養補充品
  • 提煉
  • 成品
  • 草本成分

第11章：中國中藥檢測服務市場經營模式

  • 合約檢驗
  • 內部檢查
  • 第三方檢驗機構

第12章 中國中藥檢測服務市場（依檢測速度分類）

  • 快速檢測
  • 標準測試

第13章：中國中藥檢測服務市場（依應用領域分類）

  • 真實性檢驗
  • 療效評價
  • 品管
  • 安全評估

第14章：以最終用戶分類的中藥檢測服務市場

  • 化妝品製造商
  • 食品和飲料製造商
  • 政府機構
  • 製藥公司
  • 研究所

第17章：中國中藥檢測服務市場區域分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第17章：中國中藥檢測服務市場（按群體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章：各國中藥檢測服務市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國中藥檢測服務市場

第17章：中國傳統中藥檢測服務市場

第20章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ALS Limited
  • Bureau Veritas SA
  • Charles River Laboratories International, Inc.
  • Eurofins Food & Feed Testing France SAS
  • Eurofins Scientific SE
  • Intertek Group plc
  • Laboratory Corporation of America Holdings
  • Merck KGaA
  • Merieux NutriSciences Corporation
  • NSF International
  • SGS North America Inc.
  • SGS SA
  • Tentamus Group GmbH
  • Thermo Fisher Scientific Inc.
  • TUV SUD AG
  • UL LLC
  • UL Verification Services Inc.
  • WuXi AppTec Co., Ltd.
Product Code: MRR-0A3806951A1E

The Chinese Herbal Medicine Testing Services Market was valued at USD 1.33 billion in 2025 and is projected to grow to USD 1.43 billion in 2026, with a CAGR of 7.98%, reaching USD 2.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.33 billion
Estimated Year [2026] USD 1.43 billion
Forecast Year [2032] USD 2.28 billion
CAGR (%) 7.98%

Chinese herbal medicine testing services sit at the intersection of traditional knowledge systems and cutting-edge analytical science, requiring a careful balance between cultural authenticity and rigorous modern quality control. The industry is driven by demands for safety verification, potency evaluation, and evidence-based validation to support both domestic consumption and international trade. Laboratories and testing service providers now operate within an increasingly complex environment shaped by evolving regulatory standards, advanced analytical technologies, and shifting supply chain dynamics. Consequently, stakeholders spanning manufacturers, regulators, research institutes, and contract testing laboratories must navigate multifaceted risks related to contamination, adulteration, authenticity, and batch-to-batch variability.

Against this backdrop, testing services serve multiple critical functions: they provide the analytical backbone for quality control programs, underpin safety assessments, and generate the data necessary for regulatory submissions and export compliance. Historically, testing paradigms focused predominantly on targeted chemical assays and heavy metal screening. However, the field is undergoing a methodological broadening to include molecular authentication and comprehensive profiling to meet heightened expectations for traceability and ingredient verification. In turn, this has created opportunities for specialized labs to offer differentiated services that combine multi-platform analyses, integrated data interpretation, and advisory support for manufacturers seeking to demonstrate product integrity.

As the industry matures, collaboration between scientific laboratories, regulatory bodies, and supply chain participants becomes increasingly important. Harmonization of testing approaches and transparent communication of methods and limits of detection are essential to build confidence among practitioners and consumers alike. The following sections explore transformative shifts, tariff impacts, segmentation-driven strategy implications, regional nuances, company-level dynamics, and practical recommendations to help industry leaders navigate a rapidly changing landscape.

How advancements in multi-platform analytics and evolving regulatory expectations are fundamentally changing testing strategies and supplier relationships

The landscape for testing services serving botanical therapeutics is being reshaped by a series of transformative shifts that go beyond incremental change to alter how quality, safety, and authenticity are verified. Advances in molecular biology, particularly the wider adoption of DNA-based testing, have enabled reliable species identification and adulterant detection in complex matrices where morphological or chemical markers are insufficient. Coupled with improvements in chromatographic separation and mass spectrometric sensitivity, laboratories can now construct richer chemical fingerprints that reveal processing-related changes and subtle markers of counterfeiting.

Concurrently, there is an increased expectation for integrated multi-platform workflows that combine chemical, molecular, and microbiological endpoints into single reporting frameworks. This integrative approach supports more comprehensive safety assessment and potency evaluation, reducing the risk that single-method blind spots undermine product integrity assessments. As a result, laboratories are investing in method validation, cross-platform data harmonization, and informatics solutions that enable transparent traceability and reproducible interpretations.

Regulatory requirements and payer expectations are also maturing; authorities and procurement bodies are demanding higher levels of transparency around testing methodologies, limits of detection, and certification of laboratories. This has elevated the commercial value of accredited testing providers and encouraged manufacturers to move certain quality assurance functions in-house where scale and technical capability permit. In parallel, supply chain traceability initiatives-driven by consumer demand for authenticity and by import control measures-are motivating investments in raw material verification programs and supplier surveillance strategies.

These shifts create new competitive dynamics: testing providers that offer end-to-end services with robust quality systems and consultative interpretation are increasingly preferred partners, while those that remain single-method, transactionally focused risk margin compression. In essence, the market is moving from commoditized testing transactions to outcome-oriented service relationships that emphasize risk reduction and regulatory defensibility.

Analysis of how shifting tariffs and trade barriers are driving supply chain realignment and increasing the demand for robust verification and compliance testing

Recent and emerging trade policies affecting imports and exports have introduced an added layer of complexity for testing and compliance functions, particularly where tariff measures intersect with supply chain risk management. Tariffs that target botanical raw materials or finished herbal products can influence procurement patterns, prompt supplier diversification, and alter the geographic sourcing of key ingredients. These shifts may change the profile of samples submitted for testing, increasing demand for authenticity verification and contaminant screening as new, unvetted suppliers enter commercial arrangements.

Moreover, tariff-related cost pressures encourage manufacturers to reconsider their quality assurance strategies. Some firms seek to internalize testing to exert tighter control over costs and turnaround times, while others outsource to accredited third-party laboratories with specialized capabilities that can validate suppliers more rapidly. In either scenario, the redistribution of sourcing footprints may create both short-term volatility in quality and longer-term incentives for suppliers to obtain certifications and to invest in upstream quality controls.

Tariff-driven realignment also has implications for regulatory oversight and customs inspections. Increased scrutiny at borders compels exporters to provide robust documentation, including testing certificates that demonstrate safety assessments and authenticity claims. Consequently, testing providers play a growing role as validators of compliance documentation, and their analytical reports become integral components of trade facilitation. This raises the value of standardized, transparent reporting formats that can withstand regulatory review and reduce shipment delays.

As businesses adapt, there is a noticeable emphasis on resilience: stakeholders are prioritizing supply chain mapping, redundant sourcing, and closer supplier partnerships to mitigate tariff-induced exposure. In effect, tariffs reshape not only economics but also the direction of quality assurance investments, accelerating the adoption of verification technologies and strengthening the linkage between testing capacity and trade readiness.

Strategic segmentation analysis revealing how service types, platform technologies, end-user needs, and sample categories determine laboratory capabilities and commercial positioning

Segmentation-driven insights reveal how testing services must align capabilities with the functional needs of diverse stakeholders across service types, technologies, end users, applications, sample types, business models, and testing speed requirements. When viewed through the lens of service type, providers offering chemical testing, DNA testing, heavy metal testing, microbiological testing, and pesticide residue testing are called upon to deliver not only accurate analyses but also contextual interpretation that links results to safety assessment and potency evaluation. The technology dimension further differentiates providers: chromatography, encompassing both gas and liquid chromatography, remains foundational for chemical profiling, whereas mass spectrometry, including GC-MS and LC-MS, provides the sensitivity and specificity needed for trace-level detection and untargeted screening. Polymerase chain reaction methods, from quantitative PCR to digital PCR, are increasingly important for species authentication and quantitation, and spectroscopy techniques such as infrared and UV-Vis complement orthogonal analyses for rapid screening and material characterization.

End-user requirements create distinct service expectations; cosmetics manufacturers and food and beverage producers often prioritize contaminant screening and regulatory compliance, while pharmaceutical companies and research institutes demand method validation, comprehensive profiling, and reproducible data for investigational and formulation work. Government agencies require defensible testing protocols for enforcement and public safety campaigns. Application-focused needs, whether authenticity verification, potency evaluation, quality control, or safety assessment, drive the configuration of test panels and reporting formats, shaping laboratory workflows and instrumentation investments.

Sample type categorization-from dietary supplements and extracts to finished products and raw herbal materials-affects extraction methods, matrix interference considerations, and method sensitivity requirements. Business model segmentation, including contract testing, in-house testing, and third-party testing labs, influences turnaround expectations, confidentiality arrangements, and the degree of consultative service. Finally, testing speed requirements differentiate rapid testing workflows from standard testing protocols, compelling laboratories to offer triage screening options alongside in-depth confirmatory analyses. Together, these segmentation axes inform strategic choices about capital allocation, method development priorities, and go-to-market positioning for laboratory service providers.

Regional dynamics and regulatory expectations that shape testing demand, laboratory investments, and cross-border trade readiness across global markets

Regional dynamics exert a pronounced influence on testing demand, regulatory expectations, and laboratory infrastructure, creating distinct operational priorities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, demand is shaped by a combination of consumer-driven quality expectations and regulatory scrutiny, which impels manufacturers and exporters to maintain comprehensive contaminant screening and transparent documentation. Laboratories in this region often focus on accreditation, method validation, and rapid reporting to support high-volume production cycles and cross-border trade.

In Europe, the Middle East & Africa, regulatory frameworks emphasize consumer safety and traceability, with an increasing focus on harmonized standards and import controls. This environment favors laboratories capable of producing internationally recognized certificates and performing complex multi-residue analyses that satisfy diverse regulatory regimes. The interplay between sophisticated markets in Europe and emerging markets in the Middle East & Africa creates opportunities for testing providers to offer capacity-building partnerships and remote analytical support.

Asia-Pacific presents a particularly heterogeneous landscape, with advanced testing infrastructure in some markets and rapid capacity expansion in others. Given the region's role as a major source of botanical raw materials and finished herbal products, there is substantial emphasis on raw material verification, supplier audits, and upstream quality assurance. Laboratories that combine field-level sampling protocols with centralized analytical capabilities are particularly well-positioned to serve manufacturers and exporters seeking to demonstrate provenance and compliance.

Across all regions, cross-border trade dynamics and regulatory convergence efforts are driving demand for standardized reporting, mutual recognition arrangements, and interoperable data formats. Consequently, laboratories and manufacturers that proactively align their testing practices with international expectations can reduce friction in trade and enhance market access for botanical products.

How laboratories and service providers are differentiating through integrated capabilities, consultative services, and strategic partnerships to win long-term client relationships

Company-level dynamics in the testing services sector are characterized by strategic differentiation through capabilities, accreditation, and service models. Leading laboratories are investing in integrated workflows that combine chromatographic and mass spectrometric platforms with molecular tools and microbiological methods to deliver comprehensive, multi-endpoint reports. This technical breadth, paired with strong quality management systems and external accreditation, creates a competitive advantage among customers that prioritize regulatory defensibility and supply chain transparency.

Another common strategy among prominent providers is the development of consultative relationships with end users. Rather than acting solely as transactional testing outlets, these companies offer advisory services such as method development, supplier qualification protocols, and bespoke surveillance programs that help clients de-risk sourcing decisions and streamline compliance documentation. Investments in laboratory information management systems and reporting automation enhance client experiences by delivering faster turnaround, clearer interpretation, and audit-ready documentation.

Partnerships and networked capabilities also characterize company strategies. Some firms extend their reach through collaborative arrangements with regional laboratories, enabling localized sampling and centralized confirmatory testing. Others focus on niche expertise-such as high-sensitivity contaminant detection or advanced DNA authentication-to command premium positioning within specific segments. Finally, companies are increasingly attentive to sustainability and ethical sourcing narratives, offering traceability solutions that support responsible procurement claims and help clients meet evolving consumer expectations.

Collectively, these trends indicate that competitive success is likely to accrue to organizations that combine technical excellence, consultative services, and scalable operational infrastructure while maintaining an explicit focus on regulatory alignment and client-specific value creation.

Practical actions for laboratory leaders to upgrade validation practices, expand consultative services, and strengthen data and regional strategies for resilient quality assurance

Industry leaders seeking to strengthen their market position should adopt a set of practical, high-impact actions that align laboratory capabilities with commercial and regulatory priorities. First, prioritize investment in method validation and cross-platform harmonization so that multi-endpoint reports are scientifically robust and legally defensible. Establishing standardized workflows and transparent documentation reduces audit friction and enhances client trust, particularly for exporters and regulated manufacturers.

Second, expand service offerings to include consultative elements such as supplier qualification programs, tailored surveillance testing, and interpretive reporting that ties analytical findings to practical compliance or reformulation recommendations. By shifting from pure-service delivery to outcome-driven partnerships, laboratories can capture incremental value and deepen client relationships. Simultaneously, explore modular service packages that allow clients to choose triage rapid testing followed by confirmatory analyses, thereby balancing speed and depth according to commercial needs.

Third, strengthen data management and reporting capabilities through laboratory information management systems and interoperable reporting formats. Efficient data handling accelerates turnaround and supports the generation of audit-ready reports that satisfy diverse regulatory regimes. Fourth, develop regionally tailored strategies: invest in localized sampling and logistics in supplier-heavy geographies, and emphasize accreditation and cross-recognition in markets with stringent import controls.

Finally, cultivate strategic alliances with technology providers, research institutions, and regulatory consultants to stay abreast of methodological advances and compliance trends. Such collaborations accelerate method adoption, reduce validation timelines, and enhance credibility. Taken together, these actions create a pathway for labs and manufacturers to improve risk management, support market access, and deliver demonstrable quality assurance to downstream stakeholders.

Description of the multi-source research approach combining technical review, regulatory analysis, and expert consultation to ensure practical and scientifically grounded insights

The research approach for this analysis combined a multi-source review of scientific literature, regulatory guidance, and laboratory best practices with interviews and expert consultations to ensure relevance and accuracy. Primary inputs included method validation standards, regulatory notifications, peer-reviewed studies on analytical technologies, and operational perspectives from quality and compliance professionals across manufacturing and testing organizations. This synthesis was supplemented by technical assessments of platform capabilities, including chromatography, mass spectrometry, polymerase chain reaction methods, and spectroscopy, to evaluate how each technology contributes to authentication, potency evaluation, contaminant detection, and routine quality control.

Interviews and consultations informed the practical implications of trade and regulatory developments, highlighting how supply chain dynamics and tariff measures influence laboratory workflows and client priorities. The methodology emphasized triangulation: corroborating findings across multiple sources to reduce bias and to ensure that conclusions reflect both scientific rigour and operational realities. Key topics explored included sample matrix challenges, limits of detection across methods, accreditation practices, reporting standards, and the evolving role of rapid screening versus confirmatory analysis.

Limitations of the research are acknowledged. While the analysis draws on a broad set of inputs and expert perspectives, it does not replace laboratory-specific method validation nor does it provide a substitute for regulatory consultation tailored to a particular jurisdiction. Stakeholders are encouraged to use the insights as a strategic guide and to commission lab-specific feasibility studies or method validations when implementing new analytical workflows or compliance strategies.

Closing assessment synthesizing technological, regulatory, and supply chain trends that will determine laboratory competitiveness and quality assurance outcomes

In conclusion, the testing services ecosystem that supports botanical therapeutics is navigating a period of substantial transition driven by technological innovation, evolving regulatory expectations, and shifting trade dynamics. Laboratories that invest in integrated multi-platform capabilities, rigorous method validation, and transparent reporting will be better positioned to meet the complex demands of manufacturers, regulators, and consumers. At the same time, supply chain volatility and trade measures underscore the importance of resilience-oriented strategies, including supplier qualification, diversified sourcing, and documentation practices that support cross-border compliance.

The interplay between service types, technologies, and end-user needs points to a future where quality assurance is both more technically sophisticated and more consultative. Rapid screening methods will coexist with in-depth confirmatory analyses, and laboratories that can offer flexible service models to accommodate urgency, cost, and depth will capture greater strategic value. Regional nuances in regulatory regimes and supply chain structures necessitate a market-sensitive approach to capacity deployment and partnership formation.

Ultimately, success in this evolving landscape requires a balanced focus on scientific excellence, operational agility, and client-centric service design. Organizations that align these elements will reduce commercial risk, facilitate market access, and help restore and sustain confidence in botanical products among stakeholders across the value chain.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Chinese Herbal Medicine Testing Services Market, by Service Type

  • 8.1. Chemical Testing
  • 8.2. DNA Testing
  • 8.3. Heavy Metal Testing
  • 8.4. Microbiological Testing
  • 8.5. Pesticide Residue Testing

9. Chinese Herbal Medicine Testing Services Market, by Technology

  • 9.1. Chromatography
    • 9.1.1. Gas Chromatography
    • 9.1.2. Liquid Chromatography
  • 9.2. Mass Spectrometry
    • 9.2.1. GC-MS
    • 9.2.2. LC-MS
  • 9.3. Polymerase Chain Reaction
    • 9.3.1. Digital PCR
    • 9.3.2. Quantitative PCR
  • 9.4. Spectroscopy
    • 9.4.1. Infrared
    • 9.4.2. UV-Vis

10. Chinese Herbal Medicine Testing Services Market, by Sample Type

  • 10.1. Dietary Supplements
  • 10.2. Extracts
  • 10.3. Finished Products
  • 10.4. Raw Herbal Materials

11. Chinese Herbal Medicine Testing Services Market, by Business Model

  • 11.1. Contract Testing
  • 11.2. In House Testing
  • 11.3. Third Party Testing Labs

12. Chinese Herbal Medicine Testing Services Market, by Testing Speed

  • 12.1. Rapid Testing
  • 12.2. Standard Testing

13. Chinese Herbal Medicine Testing Services Market, by Application

  • 13.1. Authenticity Verification
  • 13.2. Potency Evaluation
  • 13.3. Quality Control
  • 13.4. Safety Assessment

14. Chinese Herbal Medicine Testing Services Market, by End User

  • 14.1. Cosmetics Manufacturers
  • 14.2. Food And Beverage Manufacturers
  • 14.3. Government Agencies
  • 14.4. Pharmaceutical Companies
  • 14.5. Research Institutes

15. Chinese Herbal Medicine Testing Services Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Chinese Herbal Medicine Testing Services Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Chinese Herbal Medicine Testing Services Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Chinese Herbal Medicine Testing Services Market

19. China Chinese Herbal Medicine Testing Services Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. ALS Limited
  • 20.6. Bureau Veritas SA
  • 20.7. Charles River Laboratories International, Inc.
  • 20.8. Eurofins Food & Feed Testing France SAS
  • 20.9. Eurofins Scientific SE
  • 20.10. Intertek Group plc
  • 20.11. Laboratory Corporation of America Holdings
  • 20.12. Merck KGaA
  • 20.13. Merieux NutriSciences Corporation
  • 20.14. NSF International
  • 20.15. SGS North America Inc.
  • 20.16. SGS SA
  • 20.17. Tentamus Group GmbH
  • 20.18. Thermo Fisher Scientific Inc.
  • 20.19. TUV SUD AG
  • 20.20. UL LLC
  • 20.21. UL Verification Services Inc.
  • 20.22. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHEMICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHEMICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHEMICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DNA TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DNA TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DNA TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY HEAVY METAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY HEAVY METAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY HEAVY METAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY PESTICIDE RESIDUE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY PESTICIDE RESIDUE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY PESTICIDE RESIDUE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GAS CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GAS CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GC-MS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GC-MS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GC-MS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY LC-MS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY LC-MS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY LC-MS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY QUANTITATIVE PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY QUANTITATIVE PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY QUANTITATIVE PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY INFRARED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY INFRARED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY INFRARED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY UV-VIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY UV-VIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY UV-VIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY EXTRACTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY EXTRACTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY EXTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY FINISHED PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY FINISHED PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY FINISHED PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RAW HERBAL MATERIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RAW HERBAL MATERIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RAW HERBAL MATERIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CONTRACT TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CONTRACT TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CONTRACT TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY IN HOUSE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY IN HOUSE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY IN HOUSE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY THIRD PARTY TESTING LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY THIRD PARTY TESTING LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY THIRD PARTY TESTING LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RAPID TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RAPID TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RAPID TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY STANDARD TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY AUTHENTICITY VERIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY AUTHENTICITY VERIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY AUTHENTICITY VERIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POTENCY EVALUATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POTENCY EVALUATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POTENCY EVALUATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAFETY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAFETY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAFETY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COSMETICS MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COSMETICS MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COSMETICS MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY FOOD AND BEVERAGE MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GOVERNMENT AGENCIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GOVERNMENT AGENCIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GOVERNMENT AGENCIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 232. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 233. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 234. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 235. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 237. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 238. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. GCC CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY BUSINESS MODEL, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TESTING SPEED, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. G7 CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. G7 CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. G7 CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 268. G7 CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2032 (USD MILLION)
  • TABLE 269. G7 CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 CHINESE HERBAL MEDICINE TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY